Asian Research Journal of Gynaecology and Obstetrics https://www.journalarjgo.com/index.php/ARJGO <p style="text-align: justify;"><strong>Asian Research Journal of Gynaecology and Obstetrics</strong>&nbsp;aims to publish&nbsp;high-quality&nbsp;papers (<a href="/index.php/ARJGO/general-guideline-for-authors">Click here for Types of paper</a>) in all areas of&nbsp;‘Gynaecology and Obstetrics’. This journal facilitates the research and wishes to publish papers as long as they are technically correct, scientifically motivated. The journal also encourages the submission of useful reports of negative results. This is a quality controlled,&nbsp;OPEN&nbsp;peer-reviewed, open access INTERNATIONAL journal.</p> <p style="text-align: justify;">&nbsp;</p> en-US contact@journalarjgo.com (Asian Research Journal of Gynaecology and Obstetrics) contact@journalarjgo.com (Asian Research Journal of Gynaecology and Obstetrics) Mon, 04 Oct 2021 06:43:46 +0000 OJS 3.1.1.4 http://blogs.law.harvard.edu/tech/rss 60 COVID-19 Vaccination in Pregnancy: International Recommendations at a Glimpse https://www.journalarjgo.com/index.php/ARJGO/article/view/30180 <p>COVID-19 pandemic has affected all countries across the world. With the emergence of vaccines, scientific community has got a sense of relief. However, dilemma still persists regarding the status of COVID-19 vaccination among the pregnant population. Coming from a low-middle income country (LMIC), most women are hesitant to receive vaccination during the antenatal period. Thus, here comes the need to update ourselves regarding what the scientific committee across the globe has to say. This Editorial throws light to the current status of COVID-19 vaccination in pregnancy and what the expert committees recommend.</p> Shalini Venkatappa, Ankit Kumar Chakraborty, Avir Sarkar ##submission.copyrightStatement## https://www.journalarjgo.com/index.php/ARJGO/article/view/30180 Wed, 13 Oct 2021 00:00:00 +0000 A Rare Case of Rhabdomyosarcoma of Cervix: Fertility Preservation Options in Young Fertile Girl https://www.journalarjgo.com/index.php/ARJGO/article/view/30179 <p>Rhabdomyosarcoma are soft tissue sarcomas arising from the primitive mesenchymal cells, common in children and adolescents, but rare in adults. A 19 years old girl diagnosed with rhabdomyosarcoma of cervix treated has been treated with fertility preserving options and is followed up for recurrence of tumor and reversibility of her menstrual function. After confirmation of diagnosis, chemotherapy cycles were given followed by conservative surgery. In the follow up, patient had recurrence. To preserve the fertility of young patient, radiotherapy was given after ovarian transposition, keeping in view the patient’s and her family’s desire to preserve fertility.&nbsp; In last 18 months of follow up, patient has been found to be disease free. In recent years, conservative surgery and chemotherapy are the most favoured fertility preservation options in young patients with rhabdomyosarcoma. Radiotherapy along with laparoscopic ovaripexy is novel in management to preserve reproductive function.</p> Neelam Jain, Bharti Goel, Anju Singh, Awadhesh Kumar Pandey ##submission.copyrightStatement## https://www.journalarjgo.com/index.php/ARJGO/article/view/30179 Mon, 04 Oct 2021 00:00:00 +0000 Sudden Intrauterine Fetal Death as a Fetal Complication Due to Intrahepatic Cholestasis of Pregnancy: A Case Report https://www.journalarjgo.com/index.php/ARJGO/article/view/30183 <p>Intrahepatic cholestasis of pregnancy&nbsp;(ICP) is a liver disorder during pregnancy. ICP usually manifests during the second and third trimester of gestation and the diagnosis is based on the clinical symptoms; the presence of pruritus with a deterioration of liver tests, and typically elevated serum levels of total bile acids. The symptoms and liver function tests of ICP resolve spontaneously after delivery. ICP is associated with the risk of preterm delivery, respiratory distress syndrome, meconium-stained amniotic fluid and&nbsp;sudden intrauterine fetal death. We report a case of 23-year-old patient who was admitted to our hospital in the 32<sup>th</sup> week of pregnancy due to decreased fetal movements a month before. The clinical symptoms was pruritus and jaundice, it was appeared a three month before hospitalization. Immunology tests parasitology and virology tests were negative. The patient denied taking any medicines and herbal preparations before and during pregnancy. Total bile acids in the serum were significantly elevated (147 mg/L). Liver enzymes were raised. The abdominal ultrasound revealed a collapsed gallbladder without image of cholelithiasis. Obstetric ultrasound revealed a sudden intauterine fetal death at 23th week of pregnancy. She underwent induction of labour and delivered a death male infant.</p> M. Ait Oufkir, M. Azerki, Z. Kabba, Z. Iloughmane, H. Alami, A. Filali, Z. Tazi, R. Bezad ##submission.copyrightStatement## https://www.journalarjgo.com/index.php/ARJGO/article/view/30183 Mon, 15 Nov 2021 00:00:00 +0000 COVID 19 Infection and Delivery: Between Expectant Behavior and Emergency Extraction https://www.journalarjgo.com/index.php/ARJGO/article/view/30182 <p><strong>Background:</strong> Pregnancy is a vulnerable period needing more care and attention regarding both the mother and her fetus. Pregnant women are particularly vulnerable to respiratory pathogens and acute pneumonia since they are at an immunosuppressive state because of the physiological changes during pregnancy. The aim of this systematic review was to report the impact of corona virus on the mode of delivery, and the treatment for coronavirus given during pregnancy and its effect on fetal well-being.</p> <p><strong>Methods</strong><strong>: </strong>A systematic literature search included COVID-19 severity treatment that can be administered, successful termination and route of termination. Data regarding fetal distress, neonatal death, preterm and stillbirths, and first- and fifth-minute Apgar scores, were also collected for newborn babies. A SARS-CoV-2 positive pregnant woman (mostly in the third trimester) was defined as a patient suffering from COVID-19 pneumonia with a positive lab test of either oropharyngeal swab specimen or polymerase chain reaction.</p> <p><strong>Findings:</strong> Firstly, we note that the rate of delivery by cesarean section is more higher than the rate of vaginal delivery, 95 vaginal deliveries correspond to 34% compared with 159 cesarean deliveries (58%). Regarding the indications for the cesarean section, we have obstetric indications which represent 35.8% including preeclampsia, fetal asphyxia. On the other hand, COVID symptoms indication represents the majority of cesarean indications 64.1% (102 cases). No patients with a vaginal delivery developed severe adverse outcomes, unlike cesarean delivery, there are patients who have developed severe symptoms requiring hospitalization in an intensive care unit reported in the majority of studies. Twelve newborns (12.6%) delivered vaginally and 21 (13.2%) born by cesarean delivery were admitted to the NICU. After adjustment for confounding factors, cesarean birth was not significantly associated with an increased risk of NICU admission.</p> <p><strong>Interpretation</strong><strong>:</strong> The choice of delivery mode is based on obstetric indications and COVID symptoms. It is not clear which mode is safer, is vaginal delivery or cesarean delivery. Concerning the indications of cesarean delivery, we note that the infection Covid 19 increases the rate of cesarean section and this can be explained by two factors: either a severe Covid 19 infection requiring urgent extraction to prevent worsening of the maternal condition or the onset of fetal asphyxia, either the association between non-severe symptoms linked to the covid 19 infection and a high obstetrical risk linked to the pregnancy itself. For maternal outcomes, no patients with a vaginal delivery developed severe adverse outcomes, while 8.1% of all cesarean deliveries developed severe outcomes and required ICU admission, this result can be explained by the severity of the symptomatology linked to COVID 19 before delivery which may itself responsible for severe adverse outcomes. Regarding neonatal intensive care unit admission and according to our work, there is no significant difference between newborn by vaginal delivery and cesarean delivery, this result is related to the early decision-making for cesarean section if indicated and avoidance of risk of fetal asphyxia. Finally, we can conclude that the delivery route Appropriate in case of stable maternal and fetal status and mild to moderate symptoms of covid and absence of factors that may lead to a possible worsening is the vaginal route. In the opposite case where there is a severe symptomatology or the risk of aggravation is high, the management must be rapid and early delivery eliminate a risk factor of aggravation and save the patient and the newborn so a caesarean section may be indicated in this case. This management must take into account several elements including the age of the pregnancy, maternal and fetal well-being, which has made it difficult to define a very precise course of action.</p> <p><strong>Plain English Summary: </strong>Pregnant women are vulnerable to respiratory pathogens and acute pneumonia since they are at an immunosuppressive state because of the physiological changes during pregnancy. This systematic review aimed to report the impact of the corona virus on the mode of delivery, and the treatment for coronavirus given during pregnancy and its effect on fetal well-being. To meet this objective, five studies were screened for the eligibility criteria. The results from 279 cases reports are summarized together to facilitate interpretation. Of the 279 respondents: 95 vaginal deliveries correspond to34% compared with 159 cesarean deliveries (58%). Concerning the indications of cesarean delivery, we have: obstetrical indications hold 35.8 % of all cesarean indications (57 cases) and preeclampsia, fetal asphyxia represents an important part of these indications. On the other hand, COVID Symptoms indication represent the majority of cesarean indications 64.1% (102 cases). No patients with a vaginal delivery developed severe adverse outcomes, while 8.1% of cesarean delivery patients developed severe symptoms after delivery and required intensive care admission. Twelve newborns (12.6%) delivered vaginally and 21 (13.2%) born by cesarean delivery were admitted to the NICU. After adjustment for confounding factors, cesarean birth was not significantly associated with an increased risk of NICU admission. In conclusion; the most preferable route of delivery remains the vaginal route in the event of a stable maternal and fetal condition and mild to moderate covid symptoms and absence of factors that may lead to a possible aggravation. On the contrary, case where there is severe symptomatology or the risk of aggravation is high, the management must be rapid and early and the termination of the pregnancy can be proposed more quickly to eliminate a risk factor of aggravation and save the patient and the newborn.</p> Mustapha Hamdi, Houda Moustaide, Saad Benkirane ##submission.copyrightStatement## https://www.journalarjgo.com/index.php/ARJGO/article/view/30182 Mon, 25 Oct 2021 00:00:00 +0000